CTI Announces New Director of RWE and Senior Director of Regulatory and Scientific Affairs to Advance Drug Development Efforts

CTI (Clinical Trial and Consulting Services) has announced its new Director of Real World Evidence (RWE), Jayashri Desai. Paula Straus-Levy will assume the position of Senior Director of Regulatory and Scientific Affairs. The two additions will advance the firm’s efforts in drug development and health economics and outcomes (HEOR) research.

Vice President of Global Real World Evidence Maria João Queiroz remarks, “We are thrilled to welcome Jayashri to the team,” comments “Her experience in epidemiology and outcomes research will be valuable to both our internal team and to our external sponsors on their programs. We’re looking forward to seeing her future successes in the department.” Read more here.

(Source: CTI, 7/23/21)